Rectal Cancer

Expert care for rectal cancer with neoadjuvant chemoradiation, surgery (including sphincter-preserving techniques), and adjuvant therapy.

Back to All Treatments
Rectal Cancer

Rectal Cancer

Solid Tumors

Overview

Rectal cancer treatment requires careful coordination between medical oncology, radiation oncology, and surgery. Neoadjuvant chemoradiation is standard for locally advanced disease to shrink tumors and improve surgical outcomes.

When to Consult

After colonoscopy findings, rectal bleeding, changes in bowel habits, tenesmus, or confirmed rectal cancer diagnosis.

What to Bring

Colonoscopy reports, biopsy results, MRI pelvis (essential for staging), CT scans, CEA blood test results, MSI/MMR testing, and surgical history.

Risk Factors

Age (risk increases after 50)
Family history of colorectal cancer
Personal history of colorectal polyps or cancer
Inflammatory bowel disease (ulcerative colitis, Crohn's)
Diet high in red meat and processed foods
Low fiber diet
Obesity
Physical inactivity
Smoking
Heavy alcohol use
Type 2 diabetes
Genetic syndromes (Lynch syndrome, FAP)
Previous pelvic radiation

Causes

Genetic mutations (APC, KRAS, BRAF, P53)
Lifestyle factors (diet, exercise, smoking)
Chronic inflammation from IBD
DNA damage accumulation
Inherited genetic mutations
Environmental carcinogens
Epigenetic changes
Gut microbiome alterations

Treatment Options

Neoadjuvant Chemoradiation

Chemotherapy (typically 5-FU or capecitabine) combined with radiation therapy before surgery. Standard for stage II/III rectal cancer. Shrinks tumor, improves surgical outcomes, and may allow sphincter preservation.

Total Mesorectal Excision (TME)

Surgical removal of rectum and surrounding mesorectal tissue. Low anterior resection (LAR) preserves sphincter when possible. Abdominoperineal resection (APR) removes anus for very low tumors.

Transanal Endoscopic Microsurgery (TEM)

Minimally invasive surgery for very early-stage, small rectal cancers. Preserves rectum and sphincter function.

Watch-and-Wait Approach

For patients with complete clinical response after chemoradiation, close monitoring instead of immediate surgery. Requires careful follow-up.

Adjuvant Chemotherapy

Post-surgical chemotherapy (FOLFOX or CAPOX) to reduce recurrence risk. Typically recommended for stage II/III disease after neoadjuvant treatment.

Targeted Therapy

Bevacizumab, cetuximab, or panitumumab for advanced/metastatic disease. Based on RAS/BRAF mutation status. EGFR inhibitors only for RAS wild-type.

Immunotherapy

Pembrolizumab or nivolumab for MSI-high or dMMR rectal cancer. Highly effective for this molecular subtype.

Radiation Therapy

External beam radiation, often intensity-modulated (IMRT). May include boost to tumor bed. Short-course or long-course protocols available.

Local Ablation

Radiofrequency ablation or cryotherapy for small, localized recurrences or metastases.

Need Treatment?

Schedule a consultation to discuss treatment options for Rectal Cancer .